Overview
NRC licenses and regulates medical use of byproduct material including PET and SPECT radiopharmaceuticals and therapeutic isotopes.
Modality Focus
Regulations cover nuclear medicine PET SPECT radiopharmacy safe handling and radiation protection for staff and patients.
Key Rules
Part 35 medical use of byproduct material sets licensing training recordkeeping and safety program requirements.
Coordination
NRC works with state regulators and FDA on radiopharmaceutical approval and clinical use oversight.